![{[Name]}](https://resource.bocsci.com/structure/1835759-68-6.gif?v=2025011501)
![{[Name]}](/probes/images/structure-default.jpg?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/98924-81-3.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/361154-30-5.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/1310686-23-7.gif?v=2025011501)
Inquiry Basket
S-Acetyl-PEG3-azide | CAS 1310827-26-9
| Catalog Number | R14-0117 |
| Category | Azides |
| Molecular Formula | C₁₀H₁₉N₃O₄S |
| Molecular Weight | 277.34 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
S-Acetyl-PEG3-azide is a polyethylene glycol (PEG)-based PROTAC linker. S-Acetyl-PEG3-azide can be used in the synthesis of a series of PROTACs.
Chemical Information
Product Specification
Computed Properties
Patents
| Synonyms | S-acetyl-PEG3-N3; S-Acetyl-PEG3-Azido; Acetylthio-PEG3-C2-Azide; S-2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl ethanethioate; 1-AZIDO-3,6,9-TRIOXA-12-THIATETRADECAN-13-ONE |
| Purity | 98% |
| IUPAC Name | S-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl] ethanethioate |
| Canonical SMILES | CC(=O)SCCOCCOCCOCCN=[N+]=[N-] |
| InChI | InChI=1S/C10H19N3O4S/c1-10(14)18-9-8-17-7-6-16-5-4-15-3-2-12-13-11/h2-9H2,1H3 |
| InChIKey | PIXCCFAIMVRUDJ-UHFFFAOYSA-N |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 13 |
| Exact Mass | 277.10962727 g/mol |
| Monoisotopic Mass | 277.10962727 g/mol |
| Topological Polar Surface Area | 84.4Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 260 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
| Publication Number | Title | Priority Date |
|---|---|---|
| AU-2017348734-A1 | Pharmaceutical composition for cancer treatment and/or prevention | 2016-10-28 |
| CA-3041979-A1 | Pharmaceutical composition for cancer treatment and/or prevention | 2016-10-28 |
| JP-WO2018079740-A1 | Pharmaceutical composition for treatment and / or prevention of cancer | 2016-10-28 |
| WO-2018079740-A1 | Pharmaceutical composition for cancer treatment and/or prevention | 2016-10-28 |
| RU-2766586-C2 | Pharmaceutical composition for treatment and/or prevention of malignant tumor | 2016-10-28 |
Recommended Services
Recommended Articles
- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry
